Next Article in Journal
CRISPR-Cas9 Genome and Double-Knockout Screening to Identify Novel Therapeutic Targets for Chemoresistance in Triple-Negative Breast Cancer
Previous Article in Journal
Rethinking EPO: A Paradigm Shift in Oncology?
Previous Article in Special Issue
Does Joint Care Impact Teenage and Young Adult’s Patient-Reported Outcomes After a Cancer Diagnosis? Results from BRIGHTLIGHT_2021
 
 
Article

Article Versions Notes

Cancers 2025, 17(23), 3874; https://doi.org/10.3390/cancers17233874
Action Date Notes Link
article xml file uploaded 3 December 2025 11:03 CET Original file -
article xml uploaded. 3 December 2025 11:03 CET Update https://www.mdpi.com/2072-6694/17/23/3874/xml
article pdf uploaded. 3 December 2025 11:03 CET Version of Record https://www.mdpi.com/2072-6694/17/23/3874/pdf
article supplementary file uploaded. 3 December 2025 11:03 CET - https://www.mdpi.com/2072-6694/17/23/3874#supplementary
article html file updated 3 December 2025 11:06 CET Original file https://www.mdpi.com/2072-6694/17/23/3874/html
Back to TopTop